| Trial ID: | L6730 |
| Source ID: | NCT05737771
|
| Associated Drug: |
Dwc202213
|
| Title: |
To Compare the Pharmacokinetic Characteristics of the Fixed-dose Combination Compared to the Loose Combination
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
FDC|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: DWC202213|DRUG: DWJ1563|DRUG: DWP16001
|
| Outcome Measures: |
Primary: AUC0-t of DWP16001, AUC0-t of DWP16001, 0 to 24 hours|Cmax of DWP16001, Cmax of DWP16001, 0 to 24 hours|AUC0-t of DWC202213, AUC0-t of DWC202213, 0 to 24 hours|Cmax of DWC202213, Cmax of DWC202213, 0 to 24 hours |
|
| Sponsor/Collaborators: |
Sponsor: Daewoong Pharmaceutical Co. LTD.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
40
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2023-01-25
|
| Completion Date: |
2023-06-30
|
| Results First Posted: |
|
| Last Update Posted: |
2023-02-21
|
| Locations: |
Chungbuk National University Hospital, Cheongju-si, Seowon-gu, 28644, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT05737771
|
